000 01270 a2200373 4500
005 20250512034059.0
264 0 _c19861022
008 198610s 0 0 eng d
022 _a0163-4356
024 7 _a10.1097/00007691-198609000-00012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaciewicz, A M
245 0 0 _aCarbamazepine drug interactions.
_h[electronic resource]
260 _bTherapeutic drug monitoring
_c1986
300 _a305-17 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCarbamazepine
_xadverse effects
650 0 4 _aCimetidine
_xmetabolism
650 0 4 _aDextropropoxyphene
_xmetabolism
650 0 4 _aDrug Interactions
650 0 4 _aErythromycin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIsoniazid
_xmetabolism
650 0 4 _aLithium
_xmetabolism
650 0 4 _aPhenobarbital
_xmetabolism
650 0 4 _aPhenytoin
_xmetabolism
650 0 4 _aPrimidone
_xmetabolism
650 0 4 _aProtein Binding
650 0 4 _aTroleandomycin
_xmetabolism
650 0 4 _aValproic Acid
_xmetabolism
650 0 4 _aWarfarin
_xmetabolism
773 0 _tTherapeutic drug monitoring
_gvol. 8
_gno. 3
_gp. 305-17
856 4 0 _uhttps://doi.org/10.1097/00007691-198609000-00012
_zAvailable from publisher's website
999 _c3098210
_d3098210